80
Participants
Start Date
September 1, 2019
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Folfirinox
Patients will receive mFOLFIRINOX every 2 weeks: Oxaliplatin 65 mg/m2 IV over 3 hours on Day 1; Irinotecan 150 mg/m2 IV over 90 minutes on Day 1; Leucovorin(l-LV) 200 mg/m2 IV over 2 hours on Day 1; followed by 5-Fluorouracil 2.4 g/m2 for 46 hours continuous infusion.
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER